T. Rowe Price Investment Management, Inc. Pacific Biosciences Of California, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 7,299 shares of PACB stock, worth $9,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,299
Previous 4,888,612
99.85%
Holding current value
$9,123
Previous $5.77 Million
99.83%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PACB
# of Institutions
244Shares Held
202MCall Options Held
879KPut Options Held
847K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.3MShares$45.4 Million0.37% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$29.5 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$25.6 Million0.11% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA16.8MShares$21 Million2.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$20 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $281M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...